U.S. federal trademark · Serial No. 85643841 · Reg. No. 4653265
medical and scientific research services, namely, medical research; medical and scientific research services all in the field of muscular dystrophy, infectious diseases and viruses that respond to ribonucleic acid (RNA) modulation therapies
pharmaceuticals and pharmaceutical products for treating muscular dystrophy ((, infectious diseases and viruses that respond to ribonucleic acid (RNA)-based therapies )) ; pharmaceuticals comprising drugs based on Phosphorodiamidate Morpholino Oligomers technology platform, and drugs that modulate RNA expression
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.